Ross O.AFarrer M.JRUEY-MEEI WU2020-02-252020-02-2520070885-3185https://scholars.lib.ntu.edu.tw/handle/123456789/463719[SDGs]SDG3apolipoprotein E; arginine; glycine; leucine rich repeat kinase 2; amino acid substitution; disease course; genetic variability; geographic distribution; heterozygote detection; human; letter; Parkinson disease; priority journal; protein analysis; risk factor; Amino Acid Substitution; Humans; Parkinson Disease; Protein-Serine-Threonine Kinases; Variation (Genetics)letter10.1002/mds.21463173779192-s2.0-34249078492